Array Biopharma (ARRY) Gets Lucky
Small biopharma stocks sometimes have that one big day, the day that there investors wait for. Array Biopharma (NASDAQ:ARRY) moved higher by 30% early in the day to $3.11. The little firm entered into an…
Small biopharma stocks sometimes have that one big day, the day that there investors wait for. Array Biopharma (NASDAQ:ARRY) moved higher by 30% early in the day to $3.11. The little firm entered into an…
3M Company (NYSE: MMM) rose nearly 4% to a yearly high of $79.93 after the Post-It Notes maker was upgraded to “buy” by Jeffrey Sprague of Citigroup. The Cooper Companies Inc (NYSE: COO) surged…
These are this morning’s key day trader and active trader alert stocks. We have given more details and analysis on each stock and story with a link over to VSInvestor.com: We have given new…
Do you have to worry when biotech giants decide to spend their hard-earned cash repurchasing their own stock rather than using the cash to go purchase new pipelines? That is what we’d like to…
Tickerspy’s Stem Cell Stock Index (*RSXTM) took off today, rising nearly 13%. The movement followed a release from the National Institutes of Health (NIH) announcing that 13 embryonic stem cell lines were approved for…
Reynolds American Inc. (NYSE: RAI) has an interesting approach in M&A today. The deal is a tiny merger valued at $44 million when you consider that Reynolds has almost a $15 billion market cap,…
Human Genome Sciences, Inc. (NASDAQ: HGSI) is rasing cash. The company announced that it is selling up to 12.5 million shares of common stock. The company earmarked funds for general corporate purposes, which includes…
Merck & Co., Inc. (NYSE: MRK) barely has its Schering-Plough deal behind it. And today came the announcement of its dividend rate, but more importantly came word of a large share repurchase program. The…
Dillard’s Inc. (NYSE: DDS) rose as high as over 10% to a yearly high of $15.79 after the department-store chain was upgraded by Deutsche Bank AG. Dress Barn Inc. (NASDAQ: DBRN) rose as…
These are this Thursday’s top ten analyst upgrades, downgrades, and initiations seen in Wall Street research calls: AmerisourceBergen (NYSE: ABC) Started as Buy at UBS. ASML (NASDAQ: ASML) Cut to Neutral at B of…
At this point it is simply a rumor, but The Wall Street Journal reports that : “Senate Democrats’ health-care legislation has been estimated to cost $849 billion and to reduce the federal budget deficit by…
The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once again why much of the criticism is justified. The FDA today said that two…
Bristol-Myers Squibb Company (NYSE: BMY) is going to completely separate itself from its holdings in Mead Johnson Nutrition Company (NYSE: MJN). The company expects that the split-off will be a tax-advantaged way to divest…
NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST) rose over 70% to a yearly high of $1.70. Its rise was driven by the news that Smith & Nephew Plc (NYSE: SNN) has agreed to buy nearly all…
CareFusion Corp. (NYSE: CFN) rose over 6% to a yearly hight of $24.34 after reporting first quarter earnings of 39 cents per share, beating analyst estimates. The company also increased its earnings forecast for…